Oscar's AI-Fueled Record Profit and the Portable Coverage Pivot
The ACA insurer swung to $1B in H1 net income while quietly rebranding itself around ICHRA, AI agents and a 2x churn assumption — and the stock's 90-day tape agrees.
OSCR · Earnings Call · 2026-08-06
The Half-Year Inflection
Oscar Health delivered what it calls earnings from operations of $389 million in Q2 2026 — a $619M year-over-year swing — on revenue up 70% to $4.9B. The stock's reaction has been violent: a +121.7% 90-day tape, one of the most extreme moves in the entire market this quarter.
Today, Oscar Health announced strong second quarter 2026 results with significant year-over-year improvement across all core metrics. Oscar delivered record profitability for the first half of 2026, generating $1.1 billion in earnings from operations -- and $1 billion in net income.
MLR improved 12 points to 79.2%, and the SG&A ratio hit a record-low 14.2%. As CFO Scott Blackley put it: “We reported earnings from operations of $389 million in the second quarter, a $619 million year-over-year improvement.” — Richard Blackley, Chief Financial Officer · 2026-08-06 The fundamentals confirm it — Total Revenue hit $4.6B in Q1 2026, up 53% yoy, while Operating Income swung to +$704M — the first sustained profit in company history.
AI at Scale: From Radiology Agents to Medical Economics
The real differentiator Oscar is pushing this quarter is AI at scale. CEO Mark Bertolini unveiled the Oswell Agent pilot — a radiology agent using members' claims history and clinical interactions to recommend site of care. "1 in 4 members choose Oswell's recommended site of care and save $75 on average per appointment." The broader claim is a structural cost advantage over competitors: “we have one platform, we have one data set. As a result, we start with a huge advantage in being able to use AI at scale without having to make the investments in platform integration and data rationalization that a lot of our competitors do.” — Mark Bertolini, Chief Executive Officer · 2026-08-06
This resonates with the global tape — "Agentic AI" and "AI at scale" themes are rippling across many sectors this quarter. Oscar is one of the few insurers explicitly linking AI to margin expansion, and management expects "tens of millions of dollars in annual savings" from AI in medical-economics programs alone. Combined with the expense ratio hitting that all-time low, the story is credible enough that the stock has tripled in three months.
The ICHRA Pivot: Defined Contribution Rails
Perhaps the most strategic theme is defined contribution — Oscar's ICHRA buildout. Mark Bertolini's answer on ICHRAx was the deepest of the call: “We now have the rails upon which to run ICHRA... because network is always an issue for employers... all of a sudden, we have the largest PPO network in the nation at narrow network rates.” — Mark Bertolini, Chief Executive Officer · 2026-08-06 This is a company-unique keyword — ICHRA X (the CMS-approved Electronic Data Exchange) does not appear in any other reporter's list this cycle. The significance: Oscar is repositioning from a pure ACA insurer to a portable coverage platform for gig workers, part-timers and the early retirees demographic the CEO keeps citing as the next labor-market wave. The keyword trajectory shows "ICHRA" spiking in 2025, but "ICHRA X" as a named, competitor-inclusive EDE product is genuinely new this quarter.
Risk Adjustment: The Favorability They Didn't Bank
A huge swing factor was the CMS risk-adjustment report. Scott Blackley: “we received the final 2025 CMS risk adjustment report, which was approximately $160 million favorable to our first quarter accruals and fully recognized in the quarter.” — Richard Blackley, Chief Financial Officer · 2026-08-06 Year-to-date favorable prior-period development totals $232M. The FCF story is now extraordinary: Q1 2026 FCF (less SBC) reached $2.6B, up 207% yoy, and Effective Net Cash rose to $7.7B.
The 2026 Wakely market-morbidity report is "quite favorable," but management deliberately holds back: "we have not taken full credit for that favorability." This discipline is a direct echo of the prior call — in February, CFO Richard Blackley had flagged the risk-adjustment challenge with: “we're actually expecting our risk adjustment as a percentage of direct revenues to increase year-over-year from 25% to 26% to about 20% in 2026.” — Richard Blackley, Chief Financial Officer · 2026-02-10 That 20% is now locked in for the full year, which is why the upside feels like a genuine tailwind rather than wishful accounting.
The 2027 Rate Cycle and the Hidden Churn
One genuinely new disclosure: membership churn expectations are doubling. "I would expect that churn, we previously thought it was 1% to 2%. It's probably going to be closer to twice that amount." CMS program integrity efforts — a disenrollment wave driven by eligibility verification — are being baked into the back half. Management frames this as a timing move ("That's really a timing move and doesn't impact revenue"), and they set up payments from CMS as a liability until resolved — a conservative posture.
Against the global backdrop, where peers like CEG and CIFR both flagged "Batch Zero" energy/approval processes, Oscar stands apart: its themes (record AI-driven profitability, ICHRA, defined-contribution rails) are almost entirely company-specific, not sector boilerplate. And the price action — +121.7% in 90 days — is coherent with the fundamentals turning. This is a genuine name-in-motion: a company that just crossed from chronic losses to record profitability, with a new strategic lane (ICHRA + AI agents) that is unique in this earnings season.